The old CEACAMs find their new role in tumor immunotherapy-Reference-Cited by-同舟云学术

The old CEACAMs find their new role in tumor immunotherapy

Published:2020-06-02 Issue:6 Volume:38 Page:1888-1898
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Han Zi-Wen,Lyv Zhi-Wu,Cui Bin,Wang Ying-Ying,Cheng Jun-Ting,Zhang Ying,Cai Wen-Qi,Zhou Yang,Ma Zhao-Wu,Wang Xian-Wang,Peng Xiao-Chun,Cui Shu-Zhong,Xiang Ying,Yang Mo,Xin Hong-Wu

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10637-020-00955-w.pdf

Reference94 articles.

1. Taheri M et al (2000) Self recognition in the Ig superfamily. Identification of precise subdomains in carcinoembryonic antigen required for intercellular adhesion. J Biol Chem 275(35):26935–26943

2. Gold P, Freedman SO (1965) Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122(3):467–481

3. Beauchemin N, Arabzadeh A (2013) Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev 32(3–4):643–671

4. Kuespert K, Pils S, Hauck CR (2006) CEACAMs: their role in physiology and pathophysiology. Curr Opin Cell Biol 18(5):565–571

5. Horst AK, Wagener C (2004) CEA-Related CAMs. Handb Exp Pharmacol 165:283–341

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep Visual Proteomics reveals DNA replication stress as a hallmark of Signet Ring Cell Carcinoma;2024-08-08

2. Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC;Frontiers in Surgery;2024-06-14

3. A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration–Resistant Prostate Cancer;Clinical Cancer Research;2024-04-29

4. Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker;F1000Research;2024-04-04

5. New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo;Cancer Immunology, Immunotherapy;2024-01-27